lansoprazole has been researched along with Ventilator-Associated Pneumonia in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Group A was the treatment group, receiving lansoprazole OD 30 mg from a nasogastric tube for 14 days, while Group B, the control group, received no proton pump inhibitors or other medications for treating peptic ulcers." | 5.22 | Stress ulcer prophylaxis in patients being weaned from the ventilator in a respiratory care center: A randomized control trial. ( Chung, CS; Hsu, YL; Lee, TH; Lin, CC, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CC | 1 |
| Hsu, YL | 1 |
| Chung, CS | 1 |
| Lee, TH | 1 |
1 trial available for lansoprazole and Ventilator-Associated Pneumonia
| Article | Year |
|---|---|
Stress ulcer prophylaxis in patients being weaned from the ventilator in a respiratory care center: A randomized control trial.
Topics: Aged; Aged, 80 and over; Female; Humans; Lansoprazole; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer | 2016 |